Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?

作者信息

Bowcock Stella J, Patrick Hannah E

出版信息

Br J Haematol. 2009 Jul;146(2):220-2. doi: 10.1111/j.1365-2141.2009.07730.x. Epub 2009 May 12.

DOI:10.1111/j.1365-2141.2009.07730.x

PMID:19438503

Abstract

摘要

相似文献

Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?

Br J Haematol. 2009 Jul;146(2):220-2. doi: 10.1111/j.1365-2141.2009.07730.x. Epub 2009 May 12.

[Angiogenesis inhibitors for treatment of angiodysplasia-related gastrointestinal bleeding].

Dtsch Med Wochenschr. 2009 Sep;134(38):1893-6. doi: 10.1055/s-0029-1237529. Epub 2009 Sep 10.

Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.

Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1347-50. doi: 10.1097/MEG.0b013e32832c9346.

Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.

BMJ Case Rep. 2011 Nov 8;2011:bcr0820114585. doi: 10.1136/bcr.08.2011.4585.

Thalidomide for treatment of bleeding angiodysplasias during hemodialysis.

Ren Fail. 2008;30(10):1040-1. doi: 10.1080/08860220802389359.

Thalidomide for the treatment of bleeding angiodysplasias.

Am J Gastroenterol. 2003 Jan;98(1):221-2. doi: 10.1111/j.1572-0241.2003.07201.x.

[Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].

Ned Tijdschr Geneeskd. 2006 Sep 9;150(36):1994-7.

Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?

Haematologica. 2002 Aug;87(8):ELT34.

Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.

Eur Rev Med Pharmacol Sci. 2013 Apr;17(8):1114-6.

Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide.

Endoscopy. 2006 Oct;38(10):1036-9. doi: 10.1055/s-2006-944829.

引用本文的文献

The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review.

J Clin Med. 2024 Sep 12;13(18):5404. doi: 10.3390/jcm13185404.

Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.

Ann Hematol. 2022 Dec;101(12):2627-2631. doi: 10.1007/s00277-022-04991-9. Epub 2022 Oct 4.

Diagnostic yield of capsule endoscopy for small bowel arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.

Endosc Int Open. 2019 Feb;7(2):E282-E289. doi: 10.1055/a-0799-9820. Epub 2019 Jan 30.

Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Frontline Gastroenterol. 2018 Apr;9(2):98-104. doi: 10.1136/flgastro-2017-100870. Epub 2017 Nov 2.

Advances in the Medical Management of Vascular Anomalies.

Semin Intervent Radiol. 2017 Sep;34(3):239-249. doi: 10.1055/s-0037-1604297. Epub 2017 Sep 11.

Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.

Medicine (Baltimore). 2016 Aug;95(33):e4606. doi: 10.1097/MD.0000000000004606.

Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Front Genet. 2015 Feb 11;6:35. doi: 10.3389/fgene.2015.00035. eCollection 2015.

Optimal management of hereditary hemorrhagic telangiectasia.

J Blood Med. 2014 Oct 15;5:191-206. doi: 10.2147/JBM.S45295. eCollection 2014.

Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

World J Biol Chem. 2014 May 26;5(2):180-203. doi: 10.4331/wjbc.v5.i2.180.

Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Transl Stroke Res. 2014 Jun;5(3):316-29. doi: 10.1007/s12975-014-0343-0. Epub 2014 Apr 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验